Skip to main content

Table 1 Patients characteristics (n = 64)

From: Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma

 

Neoadjuvant CTx

Surgery n

(n = 26/64)

(n = 38/64)

Age

  

  Median (years)

64.5

73

  (range)

(38–76)

(43–91)

Sex

  

  Males

20

23

  Females

6

15

Tumor localization

  

  Proximal

20

26

  Distal

6

12

Surgical procedure

  

  Total gastrectomy

25

31

  Subtotal gastrectomy

1

7

  D2-lymphadenectomy

26

38

Resection

  

  Curative (R0)

20

28

  Palliative (R1)

6

10

UICC stage, pretherapeutic

  

  Ib

2

10

  II

7

13

  III

17

15

WHO classification

  

  Adenocarcinoma

20

31

  Signet-cell carcinoma

6

7

Grading

  

  G 1-2

6

21

  G 3

20

17

Lauren-classification

  

  Intestinal

15

21

  Diffuse

11

17